Benyamini P
Antibiotics (Basel). 2024; 13(10).
PMID: 39452186
PMC: 11504868.
DOI: 10.3390/antibiotics13100919.
Gough A, Parker A, OBryan P, Whitehead T, Roy S, Garcia B
Microbiologyopen. 2024; 13(4):e1429.
PMID: 39109824
PMC: 11304471.
DOI: 10.1002/mbo3.1429.
Hsu Y, Liu C, Wu Y, Lai S, Lin C, Tseng T
J Chem Inf Model. 2024; 64(15):6132-6146.
PMID: 39078379
PMC: 11323011.
DOI: 10.1021/acs.jcim.4c01046.
Ishikawa T, Eguchi Y, Igarashi M, Okajima T, Mita K, Yamasaki Y
J Antibiot (Tokyo). 2024; 77(8):522-532.
PMID: 38918599
PMC: 11284088.
DOI: 10.1038/s41429-024-00726-2.
Su H, Lai S, Tsai K, Fung K, Lung T, Hsu H
Comput Struct Biotechnol J. 2024; 23:1477-1488.
PMID: 38623562
PMC: 11016868.
DOI: 10.1016/j.csbj.2024.04.005.
Therapeutic Switching of Rafoxanide: a New Approach To Fighting Drug-Resistant Bacteria and Fungi.
Bendary M, Abd El-Hamid M, Abousaty A, Elmanakhly A, Alshareef W, Mosbah R
Microbiol Spectr. 2023; 11(4):e0267922.
PMID: 37458598
PMC: 10433953.
DOI: 10.1128/spectrum.02679-22.
Histidine kinase inhibitors impair shoot regeneration in cytokinin signaling and SAM patterning determinants.
Lardon R, Trinh H, Xu X, Vu L, Van De Cotte B, Pernisova M
Front Plant Sci. 2023; 13:894208.
PMID: 36684719
PMC: 9847488.
DOI: 10.3389/fpls.2022.894208.
Bacterial Two Component Systems: Overexpression and Purification: In Vitro and In Vivo Inhibitor Screens.
Dietrich A, Gajdiss M, Turck M, Monk I, Bierbaum G
Methods Mol Biol. 2022; 2601:313-333.
PMID: 36445592
DOI: 10.1007/978-1-0716-2855-3_17.
Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme.
El-Dershaby N, El-Hawash S, Kassab S, Dabees H, Abdel Moneim A, Abdel Wahab I
J Enzyme Inhib Med Chem. 2022; 37(1):1737-1751.
PMID: 35707920
PMC: 9225712.
DOI: 10.1080/14756366.2022.2086868.
Evaluation of small molecule kinase inhibitors as novel antimicrobial and antibiofilm agents.
King A, Blackledge M
Chem Biol Drug Des. 2021; 98(6):1038-1064.
PMID: 34581492
PMC: 8616828.
DOI: 10.1111/cbdd.13962.
Progress Overview of Bacterial Two-Component Regulatory Systems as Potential Targets for Antimicrobial Chemotherapy.
Hirakawa H, Kurushima J, Hashimoto Y, Tomita H
Antibiotics (Basel). 2020; 9(10).
PMID: 32977461
PMC: 7598275.
DOI: 10.3390/antibiotics9100635.
Detection of Quorum-Sensing Molecules for Pathogenic Molecules Using Cell-Based and Cell-Free Biosensors.
Miller C, Gilmore J
Antibiotics (Basel). 2020; 9(5).
PMID: 32429345
PMC: 7277912.
DOI: 10.3390/antibiotics9050259.
Synthesis of histidine kinase inhibitors and their biological properties.
Rosales-Hurtado M, Meffre P, Szurmant H, Benfodda Z
Med Res Rev. 2019; 40(4):1440-1495.
PMID: 31802520
PMC: 7272307.
DOI: 10.1002/med.21651.
Quinazoline-Based Antivirulence Compounds Selectively Target PhoP/PhoQ Signal Transduction System.
Carabajal M, Asquith C, Laitinen T, Tizzard G, Yim L, Rial A
Antimicrob Agents Chemother. 2019; 64(1).
PMID: 31611347
PMC: 7187569.
DOI: 10.1128/AAC.01744-19.
Roles of two-component regulatory systems in antibiotic resistance.
Tierney A, Rather P
Future Microbiol. 2019; 14:533-552.
PMID: 31066586
PMC: 6526388.
DOI: 10.2217/fmb-2019-0002.
Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens.
Bhagirath A, Li Y, Patidar R, Yerex K, Ma X, Kumar A
Int J Mol Sci. 2019; 20(7).
PMID: 30974906
PMC: 6480566.
DOI: 10.3390/ijms20071781.
Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study.
Shahbaaz M, Nkaule A, Christoffels A
Sci Rep. 2019; 9(1):4405.
PMID: 30867456
PMC: 6416319.
DOI: 10.1038/s41598-019-40621-7.
"In-Group" Communication in Marine : A Review of N-Acyl Homoserine Lactones-Driven Quorum Sensing.
Liu J, Fu K, Wu C, Qin K, Li F, Zhou L
Front Cell Infect Microbiol. 2018; 8:139.
PMID: 29868495
PMC: 5952220.
DOI: 10.3389/fcimb.2018.00139.
Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition.
Wilke K, Fihn C, Carlson E
Bioorg Med Chem. 2018; 26(19):5322-5326.
PMID: 29706527
PMC: 6361726.
DOI: 10.1016/j.bmc.2018.04.047.
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus.
Yeo W, Arya R, Kim K, Jeong H, Cho K, Bae T
Sci Rep. 2018; 8(1):2521.
PMID: 29410445
PMC: 5802796.
DOI: 10.1038/s41598-018-20617-5.